Discreet consultations · GPhC registered UK pharmacy
Client Support: 01709 879898

Mounjaro

Mounjaro (tirzepatide) is a once-weekly injectable medication for type 2 diabetes and weight management, offering dual hormone action for improved glycemic control and significant weight loss.
Packaging and branding may differ from image shown.

Price range: £176.99 through £334.99
Start Assessment

How Mounjaro works

Mounjaro (tirzepatide) is a once-weekly injectable prescription medication developed to support effective weight management in adults living with obesity or those who are overweight and have related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol. It belongs to a new class of medications that help regulate appetite, improve metabolic function, and promote meaningful, sustained weight loss.

With a mechanism that targets two natural gut hormones involved in appetite and insulin control, Mounjaro is suitable for individuals who have struggled to lose weight through diet and exercise alone. When used as part of a comprehensive weight loss plan, it can significantly improve both physical health and quality of life.

How It Works

Tirzepatide, the active ingredient in Mounjaro, acts on both the GIP and GLP-1 receptors in the body—hormones that help regulate insulin release and appetite. By enhancing the body’s natural satiety response, slowing gastric emptying, and reducing hunger signals, Mounjaro helps patients eat less without extreme restriction. These effects lead to gradual and sustained weight loss while also supporting blood sugar balance and improved insulin sensitivity.

This dual-hormone activity distinguishes Mounjaro from older GLP-1-only treatments, making it a powerful tool for patients needing metabolic support and weight reduction.

Why Choose Mounjaro

  • Targeted Weight Loss Aid: Designed for individuals who are overweight or obese and need medical support to manage their weight.

  • Dual Hormone Mechanism: Offers enhanced appetite control and metabolic benefits compared to single-hormone treatments.

  • Once-Weekly Injection: Simple and discreet administration helps promote adherence and long-term results.

  • Broad Health Benefits: May also support improvements in blood sugar, cholesterol, and cardiovascular risk factors when used as part of a weight loss plan.

Important Note

Mounjaro is not a substitute for healthy lifestyle choices, but it can significantly enhance the results of a weight management plan when diet and exercise alone are insufficient. It must be prescribed and monitored by a healthcare professional. This medication is not suitable for those with a history of certain thyroid or endocrine conditions. Follow all dosage instructions carefully and attend regular medical reviews to track progress and adjust treatment as needed.

Directions

Use Mounjaro KwikPen exactly as your prescriber directs and read the UK patient information leaflet and the pen instructions before use.

  • Inject under the skin once a week, ideally on the same day. Rotate the injection site each time. Your prescriber or pharmacist can show you how to use the pen.
  • Use only the strength prescribed to you. Speak to your prescriber before changing your dose.
  • If you miss a dose, take it within four days of the scheduled dose. After four days, skip it and take your next dose on your usual day. Leave at least three days between doses and never take a double dose.

Ingredients

The active ingredient is tirzepatide. Each 0.6 mL dose contains the strength printed on the pen.

Other ingredients include benzyl alcohol, glycerol, phenol, sodium chloride, water for injections, sodium phosphate dibasic heptahydrate, concentrated hydrochloric acid and sodium hydroxide.

See section 6 of the UK patient information leaflet for the full ingredients list and section 2 for information about benzyl alcohol and sodium.

Side Effects

Common side effects include nausea, diarrhoea, vomiting and constipation. Ask your pharmacist or prescriber for advice if side effects persist or make it difficult to stay hydrated. The risk of low blood sugar is higher if you also use insulin or a sulphonylurea.

Seek urgent medical help if you develop severe stomach pain that does not go away, especially if it spreads to your back or you feel or are sick. This could be pancreatitis. Stop taking Mounjaro and seek immediate help if you have trouble breathing or rapid swelling of your lips, tongue or throat.

See section 4 of the UK patient information leaflet for the full list of side effects and what to do.